Tag: DIAL
Novel Dialysis Device Safe, Effective for Acute-on-Chronic Liver Failure
No difference seen in 28-day mortality or occurrence of serious adverse events; time to resolution of ACLF significantly faster
Disparities Seen in Staph Bloodstream Infections in Hemodialysis
S. aureus bloodstream infection risk highest in Hispanic patients and in those aged 18 to 49 years
Risk for GI Bleed Increased With Hemodialysis Versus Peritoneal Dialysis
Furthermore, use of anticoagulants induces higher incidence of GI bleeding in hemodialysis versus peritoneal dialysis patients
Peritonitis Tied to Cardiovascular Mortality in Peritoneal Dialysis Population
Higher risk seen with increasing peritonitis episodes; risk for cardiovascular mortality lower for those commencing peritoneal dialysis in 2012-2019 versus 2003-2011
Environmental Sustainability Not Prioritized in Dialysis Facilities
Few facilities report having environmental sustainability strategy in place or undertaking sustainability audits
Symptom Burden Increases in Year Before Dialysis Initiation
Among older adults, symptom number and burden stabilized and decreased in the year after dialysis
Smoking Tied to Earlier Death in Dialysis Patients
Findings show higher all-cause and cardiovascular mortality
Decrease Noted in Peritoneal Dialysis-Linked Peritonitis Rates
5 percent decline seen in peritonitis rate per year; rate varied by patient factors, including age, race, prior peritoneal episodes
Peritoneal Dialysis Less Costly for Medicare Than Hemodialysis
Convergence in the costs of intravenous dialysis drugs seen between peritoneal dialysis, hemodialysis
COVID-19 Risk for Dialysis Patients Tied to Antibody Response to Vaccine
During omicron, risk for SARS-CoV-2 infection dependent on antibody response to COVID-19 vaccine regardless of number of doses
